AstraZeneca Pharma India Ltd Announce CFO Resignation Amid Move to Regional Group Role
AstraZeneca Pharma India Ltd. has confirmed the resignation of Ms. Bhavana Agrawal from her roles as Executive Director and Chief Financial Officer (CFO). The resignation is effective from the close of business hours on August 31, 2026, following her appointment to a regional role within the AstraZeneca Group.Ms. Agrawal's departure from the CFO position comes as part of a transition move, allowing her to take up responsibilities in a broader capacity across the AstraZeneca Group. The company acknowledged Ms. Agrawal for her support during her tenure with the organization.
Material details regarding Ms. Agrawal and the resignation are summarized below:
| Particulars | Detail |
|---|---|
| Reason for change | Resignation from the position of Chief Financial Officer |
| Date of Cessation | Close of business hours on August 31, 2026 |
| Shareholding in Company | NIL |
AstraZeneca Pharma India Ltd. confirmed that Ms. Agrawal resigned due to her transition to the new regional role within the AstraZeneca Group. The company has issued the necessary internal communications regarding this key management personnel change.
ASTRAZEN Stock Price Movement
Shares of AstraZeneca Pharma India Limited are shedding 0.54% as of 10:03 AM, with the stock trading down to ₹8011 in live market activity. The equity has seen intraday volatility, ranging between a low of ₹7985 and a high of ₹8102 so far today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.